Skip to main content
BIIB
NASDAQ Life Sciences

Biogen to Present Key Lecanemab SC Formulation & 3-Year Real-World Data at AAIC 2026

Tom Rudovsky · Reported by Wiseek News
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$217
Mkt Cap
$31.983B
52W Low
$121.05
52W High
$219.72
52W Position info
79% above low
Off High info
1.2% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

BIIB sits 79% above its 52-week low of $121.05.

Summary

Biogen will present significant updates on its Alzheimer's drug, Lecanemab, at the upcoming AAIC 2026 conference. The presentation will include data on a new subcutaneous (SC) at-home formulation, which could greatly improve patient convenience and access. Additionally, three-year real-world data from the LEADER study will be shared, providing crucial insights into the drug's long-term use, safety, and maintenance dosing. This news follows a period of mixed pipeline updates for Biogen, making positive developments for a key commercialized drug particularly important for its revenue outlook.

At the time of this announcement, BIIB was trading at $217.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32B. The 52-week trading range was $121.05 to $219.72. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

BIIB - Latest Insights

BIIB
Nov 18, 2026, 11:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $249.28
Real-time Price: $249.28 info
Change: $0 (0%) info
Market Cap: $36.894B info
BIIB
Nov 17, 2026, 4:45 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $253.00
Real-time Price: $249.28 info
Change: -$3.72 (-1%) info
Market Cap: $36.894B info
BIIB
Nov 09, 2026, 1:02 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $248.35
Real-time Price: $249.28 info
Change: +$0.930 (+0.37%) info
Market Cap: $36.894B info
BIIB
Oct 28, 2026, 6:23 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $249.28 info
Change: -$3.45 (-1%) info
Market Cap: $36.894B info
BIIB
Oct 28, 2026, 6:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $252.73
Real-time Price: $249.28 info
Change: -$3.45 (-1%) info
Market Cap: $36.894B info